+ Chinese + English

Home page About Granlen | News and Events | Products | Infrastructure | Culture & Career | Contact Us |

Fluoro-modified nucleosides

Halo-nucleosides

2’-Modified nucleosides

3’-Modified nucleosides

4’-Modified nucleosides

5’-Modified nucleosides

3’-Deoxy nucleosides

5’-Deoxy nucleosides

2’,3’-Dideoxy nucleosides

Didehydro-nucleosides

Azido-nucleosides

Amino nucleosides

Thio-nucleosides

Iso-cytidine derivatives

Iso-guanosine derivatives

Arabino-nucleosides

Xylo-nucleosides

2-Modified purine nucleosides

6-Modified purine nucleosides

6-De-aminopurine nucleosides

8-Modified purine nucleosides

7-Deaza-purine nucleosides

8-Aza-7-deaza-purine nucleosides

5,6-Dihydro-uridines

3-Deazauridines

4-Deoxypyrimidine nucleosides

5-Modified pyrimidine nucleosides

6-Modified pyrimidine nucleosides

Anhydro-nucleosides

Pyridine nucleosides

Bi-/Tricyclic nucleosides

Morpholino-nucleosides

N-Methylated/alkylated nucleosides

Naturally modified ribo-nucleosides

Acyclic nucleosides

LNA-related nucleosides

Phosphorus-containing nucleotides

Alpha-Nucleosides

Indole nucleosides

Protected nucleosides with NH2/OH open

2-Deoxy uridines

Other modified nucleosides

+86-0371-8551 3397

Nucleoside Derivatives

Home page > Products > Nucleoside Derivatives > 3’-Modified nucleosides

GL103265
Catalog No. GL103265 Name N⁴-Benzoyl-5’-O-(4,4’-dimethoxytrityl)-3’-O-methylcytidine Synonyms Formula C38H37N3O8 FW 663.72 CAS No. 138906-83-9 Purity ≥ 95% Property Package Packed as desired Classification Nucleoside Derivatives – 3’-Modified nucleosides; Protected nucleosides w/NH2/OH open Notes:

: About Granlen | News and Events | Products | Infrastructure | Culture & Career | Contact Us |

© 1998 - 2022 Granlen Inc. All Rights Reserved 豫ICP备19022032号-1